1022171-55-6

Basic information

• Product Name: 2-[2-(4-nitrophenyl)ethyl]-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazole
• Synonyms: 2-[2-(4-nitrophenyl)ethyl]-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazole
• CAS NO: 1022171-55-6
• Molecular Weight: 404.509
• Mol File: 1022171-55-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[2-(4-nitrophenyl)ethyl]-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(4-nitrophenyl)ethyl]-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazole(1022171-55-6)
• EPA Substance Registry System: 2-[2-(4-nitrophenyl)ethyl]-4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazole(1022171-55-6)

Safety Data

• Hazardous Substances Data: 1022171-55-6(Hazardous Substances Data)

Upstream product

• 98953-18-5 3-(4-nitrophenyl)propionamide 
• 132392-28-0 2-bromo-1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one 

Downstream Products

• 1022171-56-7 (4-{2-[4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-oxazol-2-yl]ethyl}phenyl)amine 

Relevant articles and documents

PHENYL DERIVATIVES AND THEIR USE AS A MEDICAMENT

The present invention relates to new phenylic derivatives exhibiting a good affinity for certain sub-types of cannabinoid receptors, in particular the CB2 receptors. These derivatives are of particular interest in a method for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said new phenylic derivatives and to methods for the preparation and use thereof.